Reuters -- British biotech minnow Phytopharm reported promising early test results with its Parkinson’s disease drug Cogane on Wednesday, propelling the stock as much as 350 percent higher.
Reuters -- British biotech minnow Phytopharm reported promising early test results with its Parkinson’s disease drug Cogane on Wednesday, propelling the stock as much as 350 percent higher.
